MassDevice.com +5 | The top 5 medtech stories for March 22, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Japan clears Novocure’s 2nd gen Optune device Novocure said today it won approval from the Japanese Ministry of Health, Labour and Welfare for its 2nd-gen Optune device. The Optune is a mobile device that delivers low-intensity, intermediate frequency, alternating electric fields, referred to as “tumor treating fields” to inhibit cancer cell replication and cause cancer cell death, the St. Helier, N.J.-based company said. Read more 4. Medtronic plans $2B debt flotation Medtronic today announced a series of upcoming offerings, looking to bring in approximately $2 billion. The Fridley, Minn.-based company announced 2 offerings to be held through its subsidiary Medtronic Global Holdings, or Medtronic Luxco, looking to bring in $1 billion in 1.7% senior notes due 2019 and $850 million in 3.35% senior notes due 2027. Read more 3. Hologic closes $1.7B Cynosure buy Hologic said today that it closed its $1.65 billion acquisition of Cynosure Inc. and its portfolio of medical aesthetic products and devices. Marlborough, Mass.-based Hologic paid $66 per share for a tota...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Blog News Well Plus 5 Source Type: news